COEP
Coeptis Therapeutics Inc
NASDAQ: COEP · HEALTHCARE · BIOTECHNOLOGY
$16.40
+1.17% today
Updated 2026-04-24
Market cap
$102.06M
P/E ratio
—
P/S ratio
74.88x
EPS (TTM)
$-2.81
Dividend yield
—
52W range
$7 – $21
Volume
0.0M
Coeptis Therapeutics Inc (COEP) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+46.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+242.5%
Last 8 reports
Positive reaction rate
100%
8 of 8 quarters
Largest single-day move
+276.1%
2025-08-14
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-14 | $-0.58 | — | $14.15 | $15.15 | +7.1% |
| 2025-08-14 | $-0.95 | — | $3.35 | $12.60 | +276.1% |
| 2025-04-02 | $-0.95 | -2275.0% | $3.35 | $12.60 | +276.1% |
| 2025-02-26 | $-1.42 | — | $3.35 | $12.60 | +276.1% |
| 2024-11-13 | $-1.08 | -8.0% | $3.35 | $12.60 | +276.1% |
| 2024-08-16 | $-1.70 | +5.6% | $3.35 | $12.60 | +276.1% |
| 2024-05-10 | $-0.08 | — | $3.35 | $12.60 | +276.1% |
| 2024-03-26 | $-1.33 | +58.4% | $3.35 | $12.60 | +276.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 | $-0.58 | — | $237441.00 | — |
| 2025-06-30 | $0.00 | $-0.95 | — | $200681.00 | -86.6% |
| 2025-03-31 | $-0.04 | $-0.95 | -2275.0% | $62874.00 | — |
| 2024-12-31 | — | $-1.42 | — | $1.86M | +24.1% |
| 2024-09-30 | $-1.00 | $-1.08 | -8.0% | — | — |
| 2024-06-30 | $-1.80 | $-1.70 | +5.6% | $1.50M | — |
| 2024-03-31 | — | $-0.08 | — | — | — |
| 2023-12-31 | $-3.20 | $-1.33 | +58.4% | $1.50M | — |
| 2023-09-30 | $-0.20 | $-4.60 | -2200.0% | — | — |
| 2023-06-30 | $-4.00 | $-2.37 | +40.8% | — | — |
| 2023-03-31 | $-5.60 | $-6.45 | -15.2% | — | — |
| 2022-12-31 | $-0.08 | $-2.59 | -3137.5% | — | — |
Frequently asked questions
Has Coeptis Therapeutics Inc beaten earnings estimates?
Coeptis Therapeutics Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports.
How does COEP stock react to earnings?
COEP stock has moved an average of +242.5% in the trading day following earnings over its last 8 reports, with positive reactions in 100% of those quarters.